GlobeNewswire Inc.··NaAcumen Pharma to Present Alzheimer's Drug Data at Stifel CNS Forum
Acumen Pharmaceuticals to present Alzheimer's drug candidate sabirnetug at Stifel CNS Forum on March 18, 2026, as Phase 2 trials advance.
HALOABOSPhase 2 clinical trialmonoclonal antibody